Notizie sul Mercato Azionario
Ultime notizie finanziarie · Aggiornato Mag 24, 2026
Truist Lower PT on Fifth Third Bancorp (FITB), Keeps a Buy Rating
Truist Lowers PT on Fifth Third Bancorp (FITB), Keeps a Buy Rating
The panel's net takeaway is that Truist's price target cut for FITB reflects concerns about slowing loan growth, net interest …
JD.com (JD) e BYD Entrano in una Partnership Strategica
JD.com (JD) and BYD Enters a Strategic Partnership
The panel views JD.com's partnership with BYD as a strategic move that leverages JD's logistics footprint and BYD's EV and …
Morgan Stanley Mantiene un Buy su Block (XYZ)
Morgan Stanley Maintains a Buy on Block (XYZ)
The panel is largely bearish on Block (SQ), citing risks such as potential loss of institutional memory from significant headcount …
Il tetto di $2.000 sui farmaci sta facendo risparmiare ai pensionati di Medicare oltre $1.500 all'anno in questo momento.
The $2,000 Drug Cap Is Saving Medicare Retirees Over $1,500 a Year Right Now
The $2,000 Part D cap provides significant relief for high-cost drug users but may have unintended consequences. While it increases …
Huntington Bancshares (HBAN) Presenta alla Conferenza RBC 2026, Ecco Cosa Dovresti Sapere
Huntington Bancshares (HBAN) Presents at RBC 2026 Conference, Here’s What You Should Know
The panel's net takeaway is that HBAN's guidance is solid but faces significant risks, particularly around deposit betas, merger accounting, …
Stellantis (STLA) Considerando Partnership con Case Automobilistiche Cinesi
Stellantis (STLA) Considering Partnerships With Chinese Automakers
The panel consensus is that Stellantis' exploration of partnerships with Chinese OEMs is a desperate move to address its European …
Azioni USA in Ripresa da Minimi Ribassi, Ma Chiudono in Calo
U.S. Stocks Climb Well Off Worst Levels But Still Close Lower
The panelists agree that the market's resilience despite geopolitical tensions is deceptive, with energy infrastructure damage posing a significant risk …
Come sta performando il titolo di Baxter rispetto ad altri titoli del settore dei dispositivi medici?
How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks?
The panel consensus is bearish on Baxter (BAX), citing persistent margin pressure, operational struggles, and a high debt load. While …
G2 Investment Partners Inizia una Nuova Posizione in Xometry
G2 Investment Partners Initiates a New Position in Xometry
Despite impressive revenue growth, XMTR's significant net losses and unclear path to profitability remain a concern, with varying opinions on …
SBSW Raggiunse un Ribasso Significativo al di Sotto della Media Mobile Critica
SBSW Makes Notable Cross Below Critical Moving Average
The panel consensus is bearish on Sibanye Stillwater (SBSW) due to its sensitivity to PGM prices, South African operational risks, …
BioMarin Pharmaceutical (BMRN) comunica risultati positivi dai trial in corso di VOXZOGO
BioMarin Pharmaceutical (BMRN) Reports Positive Results From Ongoing Trials of VOXZOGO
The panel discusses BioMarin's VOXZOGO (vosoritide) data, with mixed views on its commercial potential. Bulls highlight label expansion to infants …
Sarà il Nuovo Piano di Difesa Aerea della Grecia a Potenziare il Titolo di Lockheed Martin?
Will Greece's New Air Defense Plan Boost Lockheed Martin's Stock?
The panel generally agrees that the $36B Greece deal for Lockheed Martin (LMT) is geopolitically important but economically modest, with …